When it comes to how fat affects metabolic risk factors, the issue is where, not how much and the latest hot spot is the liver.
Read More »Diabetes In Control
Higher Diastolic, Not Systolic, Blood Pressure Linked to Impaired Cognition
Higher diastolic blood pressure (DBP) levels, but not systolic blood pressure (SBP) levels, can impair cognitive status in individuals without prior history of stroke or transient ischemic attack, according to the results of a large study. So being more aggressive in the treatment of hypertension can possibly prevent dementia.
Read More »Patch ‘Shots’ to Replace Injections
A skin patch lined with “microneedles” may someday offer a painless alternative to hypodermic needles, according to scientists working on the concept.
Read More »Possible Cause of Type 1 Linked to Wheat Reaction
Canadian scientists say they might have discovered a clue to the cause of Type 1 diabetes — a possible link to an abnormal response to wheat protein.
Read More »Testosterone Supplementation Benefits Men with Heart Failure
Dr. Giuseppe Caminiti of the Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Pisana in Rome, reported that long-acting testosterone injections improved exercise capacity and insulin sensitivity in elderly men with heart failure.
Read More »Type 2 Diabetes Has a Key Role in Rising Alzheimer’s Cases
Over the next 40 years there could be a flood of dementia associated with Type 2 diabetes.
Read More »The Most Effective Therapy for Diabetes Induced Alzheimers
“Exercise is the most potent insulin-sensitizing agent we have,” said Dr. Suzanne Craft, a geriatrician and Alzheimer’s researcher at the Veterans Administration Puget Sound Health Care System, Seattle, Washington.
Read More »FDA Releases New Safety Warnings for Orlistat – Alli – Xenical
FDA notified healthcare professionals and patients that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat.
Read More »Letter from the Editor: August 26, 2009, Issue #483
Humulin U-500 insulin once again is on my agenda, as I had three calls from hospital pharmacists and educators asking for a method to convert and write orders for patients on pumps and for sliding scale use. Many of our syringe or pen patients are injecting 60 or more units …
Read More »Certain Diabetes Therapies May be Associated with Pancreatic Cancer Risks
Metformin appears to reduce the risk for pancreatic cancer in patients with diabetes, whereas insulin therapy appears to increase the risk, according to the results of a large case-control study.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.